The effect on fat mass, and associated traits, is likely secondary, as suggested by its dependence on BMI, while we foresee a direct effect of SMIM1 on dyslipidemia and liver function as these parameters continue to hold significance even after BMI correction. This evidence concerns the gene SMIM1 and metabolic syndrome.